Thomas Hankeln Selected Research

Neuroglobin

2/2011	Changes of globin expression in the Japanese medaka (Oryzias latipes) in response to acute and chronic hypoxia.
12/2010	Neuroglobin, cytoglobin, and myoglobin contribute to hypoxia adaptation of the subterranean mole rat Spalax.
10/2010	Cerebral expression of neuroglobin and cytoglobin after deep hypothermic circulatory arrest in neonatal piglets.
5/2009	What is the function of neuroglobin?
7/2008	Globins and hypoxia adaptation in the goldfish, Carassius auratus.
1/2007	Regulation and role of neuroglobin and cytoglobin under hypoxia.
8/2006	Neuroglobin mRNA expression after transient global brain ischemia and prolonged hypoxia in cell culture.
6/2006	Hypoxia induces a complex response of globin expression in zebrafish (Danio rerio).
2/2005	Divergent distribution of cytoglobin and neuroglobin in the murine eye.
1/2005	Neuroglobin and cytoglobin in search of their role in the vertebrate globin family.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Hankeln Research Topics

Disease

26	Hypoxia (Hypoxemia) 01/2023 - 08/2002
22	Neoplasms (Cancer) 01/2023 - 12/2011
8	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2011
5	Second Primary Neoplasms (Neoplasms, Second) 01/2023 - 11/2021
2	Inflammation (Inflammations) 01/2024 - 10/2004
2	Genomic Instability 01/2023 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2023 - 10/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 10/2014
2	Hyperoxia 06/2012 - 10/2008
2	Ischemia 02/2009 - 08/2006
2	Ganglion Cysts (Ganglion) 02/2005 - 01/2003
1	Hepatoblastoma 11/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Carcinogenesis 01/2023
1	Obesity 01/2023
1	Overweight 01/2023
1	Nervous System Diseases (Neurological Disorders) 10/2022
1	Ductal Carcinoma 09/2022
1	Colitis-Associated Neoplasms 01/2022
1	Colonic Neoplasms (Colon Cancer) 02/2020
1	Chronic Renal Insufficiency 01/2020
1	Chromosomal Instability (Chromosome Stability) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 12/2016
1	Fetal Hypoxia 11/2016
1	Hypercapnia 06/2014
1	Congenital Heart Defects (Congenital Heart Defect) 10/2010
1	Brain Injuries (Brain Injury) 10/2010
1	Necrosis 10/2010
1	Malaria 04/2007
1	Wounds and Injuries (Trauma) 08/2006
1	Brain Ischemia (Cerebral Ischemia) 08/2006

Drug/Important Bio-Agent (IBA)

14	NeuroglobinIBA 02/2011 - 10/2002
13	MyoglobinIBA 01/2023 - 06/2006
9	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2003
9	CytoglobinIBA 01/2020 - 02/2004
9	Messenger RNA (mRNA)IBA 11/2016 - 01/2003
8	Oxygen (Dioxygen)IBA 09/2022 - 01/2005
8	GlobinsIBA 01/2022 - 06/2006
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 08/2002
4	Hemoglobins (Hemoglobin)IBA 02/2011 - 06/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2014
3	Hormones (Hormone)IBA 12/2016 - 10/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2023 - 10/2010
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 06/2012
2	Phenobarbital (Luminal)FDA Link 09/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2020 - 06/2014
2	AntioxidantsIBA 02/2016 - 06/2012
2	AndrogensIBA 01/2015 - 10/2014
2	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 02/2011 - 06/2006
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2008 - 07/2008
2	Lactate Dehydrogenase 5IBA 10/2008 - 06/2006
1	XenobioticsIBA 01/2024
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2024
1	RetinoidsIBA 01/2024
1	Protein Isoforms (Isoforms)IBA 11/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2022
1	ClusterinIBA 10/2022
1	Neuroprotective AgentsIBA 10/2022
1	Carrier Proteins (Binding Protein)IBA 09/2022
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2022
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	AzoxymethaneIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Small Interfering RNA (siRNA)IBA 02/2020
1	ProstaglandinsIBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	NucleotidesIBA 04/2017
1	Peptides (Polypeptides)IBA 04/2017
1	N-acetyltalosaminuronic acid (NAT)IBA 12/2016
1	ElementsIBA 01/2015
1	Estrogens (Estrogen)FDA Link 01/2015
1	Protein SIBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014
1	SteroidsIBA 10/2014
1	Androgen Receptors (Androgen Receptor)IBA 10/2014
1	LuciferasesIBA 01/2014
1	ErbB Receptors (EGF Receptor)IBA 11/2012
1	EnzymesIBA 12/2011
1	Codon (Codons)IBA 12/2011
1	Carbonic Anhydrase IXIBA 12/2011
1	Cyclophilins (Cyclophilin)IBA 02/2011
1	ribosomal protein P0IBA 02/2011
1	lactate dehydrogenase 1 (LDH1)IBA 02/2011
1	AdrenomedullinIBA 02/2011
1	Superoxide DismutaseIBA 07/2008
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2004

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2020
2	Radiotherapy 01/2023 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2023
1	Aftercare (After-Treatment) 01/2021
1	Immunotherapy 04/2017
1	Deep Hypothermia Induced Circulatory Arrest 10/2010